EDGAR Filing Documents for 0001493152-23-018786

Form 8-K - Current report:

SEC Accession No. 0001493152-23-018786

Filing Date

2023-05-24

Accepted

2023-05-24 08:45:17

Documents

Period of Report

2023-05-18

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	72390
2		ex10-1.htm	EX-10.1	72564
3		ex10-2.htm	EX-10.2	184172
4		ex10-3.htm	EX-10.3	32649
5		ex10-4.htm	EX-10.4	89672
6		ex10-5.htm	EX-10.5	188640
7		ex10-6.htm	EX-10.6	29653
8		ex10-7.htm	EX-10.7	85993
9		ex99-1.htm	EX-99.1	42333
10		ex99-2.htm	EX-99.2	43739
11		ex99-3.htm	EX-99.3	2317
12		ex10-1_001.jpg	GRAPHIC	1818
13		ex10-1_002.jpg	GRAPHIC	752
14		ex99-1_001.jpg	GRAPHIC	22009
15		ex99-1_002.jpg	GRAPHIC	21106
16		ex99-2_002.jpg	GRAPHIC	3254
17		ex99-3_001.jpg	GRAPHIC	1378690
18		ex99-3_002.jpg	GRAPHIC	1685280
19		ex99-3_003.jpg	GRAPHIC	961755
	Complete submission text file	0001493152-23-018786.txt		6789809

Data Files

Seq	Description	Document	Type	Size
20	XBRL SCHEMA FILE	rspi-20230518.xsd	EX-101.SCH	3230
21	XBRL LABEL FILE	rspi-20230518_lab.xml	EX-101.LAB	34240
22	XBRL PRESENTATION FILE	rspi-20230518_pre.xml	EX-101.PRE	22361
24	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3292

Mailing Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452

Business Address 126 VALLEY ROAD SUITE C GLEN ROCK NJ 07452 (201) 444-4947

RespireRx Pharmaceuticals Inc. (Filer) CIK: 0000849636 (see all company filings)